Apex Noire Cannabis

Apex Noire Cannabis is seeking investment
to fuel growth while sharing our success with the Boston community.

Print
Claim My Business
Form C
View on Mainvest
Security Type
Revenue Sharing
Categories
Cannabis & Smoke Products
Min Investment
$100
Location
DORCHESTER, MA
Expected Close Date
May 15, 2024
Target Raise
$25.00K-$125.00K
No. Investors
313
Security Price
$1
Website
ApexNoire.Com
Number of Employees
1
Cash
$45,126
Revenue
$0
Short Term Debt
$1,312,586
Cost of Goods
$0
Long Term Debt
$3,538,425
Net Income
$-878,423

Company Description

Apex Noire is Boston's first 7 story full service experiential cannabis retail location, primely placed in Faneuil Hall, the 7th Most Visited Destination in the world and the international tourist mecca of New England. With this Mainvest phase, we're launching phase one of our grassroots community fundraising efforts, with preferred returns to early investors.

Amount Raised : $390,300
Reveal the Score by Voting
＿
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
ⓘ
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
ⓘ
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
ⓘ
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
ⓘ
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

Revenue Sharing is a form of lending that involves sharing revenue from the business with investors as return on their investment. It is often a fixed percentage of revenue and you are paid until you earn a total return on your investment.

Research Reports

No reports have been submitted

Become a Reporter
Read Our Research Disclaimer

0 Comments

Post Comment